July 11th 2025
ICE federal agents raided cannabis nurseries in Southern California, sparking protests from migrant-rights activists.
Cannabinoid Isomers Such as Delta-8: Navigating Regulations and Safety Concerns
June 1st 2022Delta-8 and delta-10 have gained considerable traction over the past year. Although these cannabinoid isomers fall in an extreme grey area, consumers are driving up demand. They can be purchased in many different forms and are commonly found in vaping products, gummies, and tinctures. Since these isomers are commonly derived from hemp extract, many consumers see delta-8 and delta-10 as a lawful hemp-derived good that provides a psychoactive effect. Per a new stance from the federal government, vaping products with these isomers fall under the 2018 Farm Bill. Even with the Food and Drug Administration’s (FDA) stance regarding the 2018 Farm Bill exempting hemp from the Controlled Substances Act (CSA), the popular edible cannabinoid isomers are not automatically legal.
What to Expect with Product Recalls
April 27th 2022In the cannabis industry there seems to be a misconception that your company will never have a recall in its lifetime, or that there isn’t any possibility it will ever happen to you. In reality, all cannabis companies experience at least one or multiple recalls during their lifetime. It isn’t about if it will happen, it’s more of a when. And when it happens, how will your company handle it?
Tricky Terpenes: Under-Regulated Use of Added Terpenes in a Regulated Cannabis Industry
February 28th 2022Terpenes can be tricky. Although cannabis is heavily regulated, since cannabis-derived terpenes do not contain tetrahydrocannabinol (THC) and other cannabinoids, they are not regulated in the same way that cannabis is.
Compliance Matters: An Insider’s Perspective on How to Stay Up to Date on Cannabis Regulations
January 31st 2022Regulations and compliance are sometimes deemed a necessary evil, but consumer and employee safety are at the heart of those rules. The cannabis industry faces unique challenges when it comes to compliance because each state has their own rules. Federal regulation would certainly simplify matters, but until then Kim Stuck, CEO and founder of Allay Consulting, offers some practical advice for how to stay ahead of potential issues. Here, Stuck shares her background in regulatory work, the cannabis industry, her new blog coming out in Cannabis Science and Technology next month, and more.
The Cannabis Vaping Industry Faces New Struggles
September 3rd 2021The COVID-19 pandemic affected all types of businesses, such as those found in the cannabis industry. Though it was hit hard from the virus, the cannabis industry suffered another blow in the form of the December 2020 COVID-19 stimulus package, which included a provision classifying all vape products as cigarettes, subjecting them to the same regulations as cigarettes. Here, U.S. Navy veteran Dana E. Shoched, president and chief executive officer of O2VAPE, discusses the impacts this legislation may have on the cannabis vaping industry.
GACP and GMP in the Medicinal Cannabis Industry—Is There a Clear Difference?
December 4th 2020This article intends to clarify the main goals of GACP and GMP guidelines, identify differences between the two, and also explore why it is important, when operating within the medicinal cannabis sector, that these two guidelines are complied with and their standards achieved.